結果ページ11 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (656)
- オーストラリア (49)
- オーストリア (11)
- ベルギー (6)
- ブラジル (14)
- カナダ (48)
- 中国 (91)
- デンマーク (5)
- フィンランド (4)
- フランス (27)
- ドイツ (449)
- 香港 (46)
- インド (19)
- イスラエル (12)
- イタリア (3)
- 日本 (37)
- メキシコ (22)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (10)
- ポーランド (8)
- ロシア (2)
- 韓国 (20)
- スペイン (4)
- スウェーデン (55)
- スイス (8)
- 台湾 (60)
- タイ (2)
- トルコ (1)
- イギリス (24)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (49)
- Brussels (6)
- BSE (9)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (5)
- Frankfurt (395)
- Helsinki (4)
- HKSE (46)
- IOB (24)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (22)
- Milan (3)
- Munich (17)
- NSE (10)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (41)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (6)
- Paris (27)
- São Paulo (14)
- Shanghai (46)
- Shenzhen (45)
- Stockholm (55)
- Stuttgart (24)
- Swiss (8)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (156)
- Tech Market Middle (85)
- Tech Market Small (211)
- Tel Aviv (12)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (13)
バイオテクノロジー (1697)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Roivant Sciences Ltd. 87S.F | €17.34 18.95 USD |
-3.29
|
€12.06B 13.18B USD | €100.00 109.31 USD | €17.34 18.95 USD | €17.81 19.46 USD | €12.06B 13.18B USD | 0 | -€0.85 -0.9 USD | ||
| Ascendis Pharma A/S A1SN34.SA | R$70.21 14.23 USD |
0
|
R$64.94B 13.16B USD | R$0.00 0 USD | R$70.21 14.23 USD | R$70.21 14.23 USD | R$64.94B 13.16B USD | 0 | -R$23.62 -4.7 USD | ||
| Ionis Pharmaceuticals, Inc. IONS.MX | MX$1,150.00 68.09 USD |
0
|
MX$210.20B 12.45B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$210.20B 12.45B USD | 0 | -MX$29.32 -1.7 USD | ||
| Moderna, Inc. MRNA.MX | MX$511.70 30.3 USD |
+1.03
|
MX$202.35B 11.98B USD | MX$666.00 39.44 USD | MX$501.22 29.68 USD | MX$512.71 30.36 USD | MX$202.35B 11.98B USD | 0 | -MX$146.90 -8.7 USD | ||
| Madrigal Pharmaceuticals, Inc. YDO1.F | €478.60 523.17 USD |
-2.09
|
€10.87B 11.88B USD | €45.00 49.19 USD | €477.00 521.43 USD | €485.00 530.17 USD | €10.87B 11.88B USD | 0 | -€11.07 -12.1 USD | ||
| BioMarin Pharmaceutical Inc. B1MR34.SA | R$146.86 29.77 USD |
+2.61
|
R$57.17B 11.59B USD | R$100.00 20.27 USD | R$146.86 29.77 USD | R$146.86 29.77 USD | R$57.17B 11.59B USD | 20.53 | R$7.15 1.45 USD | ||
| BioMarin Pharmaceutical Inc. BMRN.MX | MX$980.00 58.03 USD |
0
|
MX$190.85B 11.3B USD | MX$0.00 0 USD | MX$980.00 58.03 USD | MX$980.00 58.03 USD | MX$190.85B 11.3B USD | 19.95 | MX$49.10 2.91 USD | ||
| Ascendis Pharma A/S A71.F | €168.00 183.65 USD |
-3.45
|
€10.26B 11.22B USD | €8.00 8.75 USD | €168.00 183.65 USD | €176.00 192.39 USD | €10.26B 11.22B USD | 0 | -€3.82 -4.1 USD | ||
| Exelixis, Inc. EX9.F | €35.88 39.22 USD |
-6.32
|
€10.02B 10.95B USD | €160.00 174.9 USD | €35.88 39.22 USD | €35.88 39.22 USD | €10.02B 10.95B USD | 17.58 | €2.04 2.23 USD | ||
| Financière de Tubize SA FTD.F | €220.00 240.49 USD |
-0.23
|
€9.79B 10.7B USD | €100.00 109.31 USD | €220.00 240.49 USD | €220.00 240.49 USD | €9.79B 10.7B USD | 105.76 | €2.08 2.27 USD | ||
| Moderna, Inc. MRNA.VI | €24.01 26.24 USD |
+0.8
|
€9.65B 10.55B USD | €2.36K 2.58K USD | €23.76 25.97 USD | €23.95 26.18 USD | €9.65B 10.55B USD | 0 | -€6.91 -7.5 USD | ||
| Financière de Tubize SA FTD.SG | €216.00 236.12 USD |
-2.04
|
€9.61B 10.51B USD | €0.00 0 USD | €215.50 235.57 USD | €219.50 239.94 USD | €9.61B 10.51B USD | 103.34 | €2.09 2.28 USD | ||
| Moderna, Inc. 0QF.F | €24.41 26.68 USD |
+5.28
|
€9.60B 10.5B USD | €70.00 76.52 USD | €23.67 25.87 USD | €24.41 26.68 USD | €9.60B 10.5B USD | 0 | -€6.92 -7.5 USD | ||
| Bio-Techne Corporation T1CH34.SA | R$11.06 2.24 USD |
0
|
R$51.70B 10.48B USD | R$0.00 0 USD | R$11.06 2.24 USD | R$11.06 2.24 USD | R$51.70B 10.48B USD | 122.88 | R$0.09 0.02 USD | ||
| Moderna, Inc. 0QF.MU | €23.75 25.96 USD |
+0.85
|
€9.47B 10.35B USD | €20.00 21.86 USD | €23.75 25.96 USD | €23.75 25.96 USD | €9.47B 10.35B USD | 0 | -€6.92 -7.5 USD | ||
| Bio-Techne Corporation TECH.MX | MX$1,090.00 64.54 USD |
-2.83
|
MX$173.19B 10.26B USD | MX$0.00 0 USD | MX$1,090.00 64.54 USD | MX$1,090.00 64.54 USD | MX$173.19B 10.26B USD | 42.91 | MX$25.40 1.5 USD | ||
| BioMarin Pharmaceutical Inc. BM8.F | €45.49 49.73 USD |
-0.07
|
€8.96B 9.8B USD | €108.00 118.06 USD | €45.49 49.73 USD | €45.49 49.73 USD | €8.96B 9.8B USD | 19.69 | €2.31 2.53 USD | ||
| BioMarin Pharmaceutical Inc. BMRN.VI | €46.04 50.33 USD |
+1.34
|
€8.94B 9.77B USD | €0.00 0 USD | €45.41 49.64 USD | €46.04 50.33 USD | €8.94B 9.77B USD | 19.93 | €2.31 2.53 USD | ||
| ABIVAX Société Anonyme AAVXF | $113.00 — |
0
|
$9.73B — | $5.10K — | $110.00 — | $110.10 — | $9.73B — | 0 | -$3.59 — | ||
| Jazz Pharmaceuticals plc J7Z.F | €142.30 155.55 USD |
-1.76
|
€8.65B 9.45B USD | €40.00 43.73 USD | €142.30 155.55 USD | €145.10 158.61 USD | €8.65B 9.45B USD | 0 | -€5.29 -5.7 USD | ||
| ALK-Abelló A/S AKBLF | $36.14 — |
+0.22
|
$9.06B — | $100.00 — | $33.05 — | $33.05 — | $9.06B — | 46.33 | $0.78 — | ||
| Arrowhead Pharmaceuticals, Inc. HDP1.F | €59.60 65.15 USD |
+13.87
|
€8.18B 8.94B USD | €57.00 62.31 USD | €58.00 63.4 USD | €59.60 65.15 USD | €8.18B 8.94B USD | 0 | -€0.01 -0.01 USD | ||
| ABIVAX Société Anonyme 2X1.F | €105.00 114.78 USD |
+5.85
|
€8.18B 8.94B USD | €131.00 143.2 USD | €98.90 108.11 USD | €105.00 114.78 USD | €8.18B 8.94B USD | 0 | -€3.09 -3.3 USD | ||
| Halozyme Therapeutics, Inc. HALO.MX | MX$1,275.01 75.5 USD |
0
|
MX$150.81B 8.93B USD | MX$0.00 0 USD | MX$1,275.01 75.5 USD | MX$1,275.01 75.5 USD | MX$150.81B 8.93B USD | 14.74 | MX$86.45 5.12 USD | ||
| Bio-Techne Corporation TE1.F | €51.50 56.3 USD |
0
|
€8.02B 8.77B USD | €4.00 4.37 USD | €51.50 56.3 USD | €51.50 56.3 USD | €8.02B 8.77B USD | 122.61 | €0.42 0.46 USD | ||
| Corcept Therapeutics Incorporated HTD.F | €71.32 77.96 USD |
+0.28
|
€7.58B 8.28B USD | €400.00 437.25 USD | €71.32 77.96 USD | €71.32 77.96 USD | €7.58B 8.28B USD | 95.09 | €0.75 0.82 USD | ||
| 3SBio Inc. 83B.F | €3.08 3.37 USD |
-2.53
|
€7.34B 8.02B USD | €280.00 306.08 USD | €3.02 3.3 USD | €3.14 3.43 USD | €7.34B 8.02B USD | 25.66 | €0.12 0.13 USD | ||
| SK Biopharmaceuticals Co., Ltd. 326030.KS | ₩135,100 101.98 USD |
+1.35
|
₩11T 7.99B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩11T 7.99B USD | 0 | ₩0 0 USD | ||
| ALK-Abelló A/S 4AJ0.F | €30.14 32.95 USD |
-0.92
|
€6.87B 7.51B USD | €51.00 55.75 USD | €30.14 32.95 USD | €30.14 32.95 USD | €6.87B 7.51B USD | 44.98 | €0.67 0.73 USD | ||
| Cytokinetics, Incorporated KK3A.F | €54.50 59.58 USD |
-0.91
|
€6.66B 7.28B USD | €165.00 180.37 USD | €54.50 59.58 USD | €54.50 59.58 USD | €6.66B 7.28B USD | 0 | -€5.41 -5.9 USD | ||
| Axsome Therapeutics, Inc. 19X.F | €125.35 137.02 USD |
-0.99
|
€6.34B 6.93B USD | €20.00 21.86 USD | €125.35 137.02 USD | €125.35 137.02 USD | €6.34B 6.93B USD | 0 | -€4.01 -4.3 USD | ||
| Halozyme Therapeutics, Inc. RV7.F | €53.72 58.72 USD |
-1.54
|
€6.32B 6.91B USD | €32.00 34.98 USD | €53.72 58.72 USD | €53.72 58.72 USD | €6.32B 6.91B USD | 13.19 | €4.07 4.45 USD | ||
| ABL Bio Inc. 298380.KQ | ₩186,200 140.55 USD |
-0.32
|
₩9T 6.82B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩9T 6.82B USD | 0 | ₩0 0 USD | ||
| Sirius XM Holdings Inc. R 3HY.F | €18.40 20.11 USD |
-0.54
|
€6.24B 6.82B USD | €60.00 65.59 USD | €18.40 20.11 USD | €18.40 20.11 USD | €6.24B 6.82B USD | 5.25 | €3.50 3.83 USD | ||
| Merus N.V. 2GH.F | €80.00 87.45 USD |
-0.62
|
€6.19B 6.77B USD | €7.00 7.65 USD | €80.00 87.45 USD | €80.50 88 USD | €6.19B 6.77B USD | 0 | -€4.53 -4.9 USD | ||
| Rhythm Pharmaceuticals, Inc. 1RV.F | €85.50 93.46 USD |
-0.58
|
€5.85B 6.39B USD | €80.00 87.45 USD | €85.50 93.46 USD | €89.00 97.29 USD | €5.85B 6.39B USD | 0 | -€2.66 -2.9 USD | ||
| Krystal Biotech, Inc. 4KB.SG | €200.00 218.63 USD |
-1.82
|
€5.80B 6.34B USD | €0.00 0 USD | €200.00 218.63 USD | €200.00 218.63 USD | €5.80B 6.34B USD | 34.96 | €5.72 6.25 USD | ||
| Krystal Biotech, Inc. 4KB.F | €200.00 218.63 USD |
+0.05
|
€5.80B 6.34B USD | €13.00 14.21 USD | €200.00 218.63 USD | €200.00 218.63 USD | €5.80B 6.34B USD | 34.96 | €5.72 6.25 USD | ||
| Biocon Limited BIOCON.BO | ₹383.55 4.64 USD |
-0.13
|
₹512.07B 6.2B USD | ₹90.55K 1.1K USD | ₹375.90 4.55 USD | ₹386.90 4.68 USD | ₹512.07B 6.2B USD | 96.61 | ₹3.97 0.05 USD | ||
| Zealand Pharma A/S ZLDPF | $79.80 — |
0
|
$5.74B — | $100.00 — | $79.80 — | $79.80 — | $5.74B — | 5.60 | $14.23 — | ||
| Vaxcyte, Inc. 5VA.MU | €39.40 43.07 USD |
0
|
€5.21B 5.7B USD | €0.00 0 USD | €39.40 43.07 USD | €39.40 43.07 USD | €5.21B 5.7B USD | 0 | -€4.16 -4.5 USD | ||
| Vaxcyte, Inc. 5VA.F | €37.60 41.1 USD |
-1.05
|
€5.16B 5.64B USD | €120.00 131.18 USD | €37.60 41.1 USD | €37.60 41.1 USD | €5.16B 5.64B USD | 0 | -€4.17 -4.5 USD | ||
| LigaChem Biosciences Inc. 141080.KQ | ₩183,200 138.29 USD |
+0.11
|
₩7T 5.04B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩7T 5.04B USD | 0 | ₩0 0 USD | ||
| Genscript Biotech GNNSF | $2.12 — |
0
|
$4.63B — | $100.00 — | $2.12 — | $2.12 — | $4.63B — | 0 | -$0.04 — | ||
| TG Therapeutics, Inc. NKB2.F | €26.15 28.58 USD |
+0.27
|
€4.15B 4.54B USD | €88.00 96.2 USD | €26.15 28.58 USD | €26.15 28.58 USD | €4.15B 4.54B USD | 10.98 | €2.38 2.6 USD | ||
| Zealand Pharma A/S 0NZU.IL | DKK 505.85 74.17 USD |
-3.63
|
DKK 30.16B 4.42B USD | DKK 14.59K 2.14K USD | DKK 502.30 73.65 USD | DKK 531.60 77.94 USD | DKK 30.16B 4.42B USD | 0 | -DKK 15.13 -2.2 USD | ||
| ALK-Abelló A/S 0OIR.IL | DKK 149.45 21.91 USD |
0
|
DKK 30.00B 4.4B USD | DKK 20.14K 2.95K USD | DKK 223.80 32.81 USD | DKK 227.80 33.4 USD | DKK 30.00B 4.4B USD | 92.82 | DKK 1.61 0.24 USD | ||
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | €8.30 9.07 USD |
-3.49
|
€3.94B 4.31B USD | €55.00 60.12 USD | €8.30 9.07 USD | €8.30 9.07 USD | €3.94B 4.31B USD | 23.71 | €0.35 0.38 USD | ||
| Scholar Rock Holding Corporation 2QK.F | €38.60 42.2 USD |
+0.52
|
€3.94B 4.3B USD | €115.00 125.71 USD | €38.60 42.2 USD | €38.60 42.2 USD | €3.94B 4.3B USD | 0 | -€2.71 -2.9 USD | ||
| Agios Pharmaceuticals, Inc. AGIO.MX | MX$1,222.00 72.36 USD |
0
|
MX$71.26B 4.22B USD | MX$0.00 0 USD | MX$1,222.00 72.36 USD | MX$1,222.00 72.36 USD | MX$71.26B 4.22B USD | 5.16 | MX$236.58 14.01 USD | ||
| Akero Therapeutics, Inc. 0K4.F | €46.53 50.86 USD |
0
|
€3.85B 4.21B USD | €75.00 81.99 USD | €46.53 50.86 USD | €46.53 50.86 USD | €3.85B 4.21B USD | 0 | -€3.22 -3.5 USD | ||
| Legend Biotech Corporation 9LB.F | €20.80 22.74 USD |
-7.14
|
€3.84B 4.2B USD | €485.00 530.17 USD | €20.80 22.74 USD | €23.60 25.8 USD | €3.84B 4.2B USD | 0 | -€1.10 -1.2 USD | ||
| Viking Therapeutics, Inc. 1VT.F | €32.55 35.58 USD |
+0.02
|
€3.68B 4.02B USD | €200.00 218.63 USD | €32.11 35.1 USD | €32.55 35.58 USD | €3.68B 4.02B USD | 0 | -€1.82 -1.9 USD | ||
| BB Biotech AG BB.MI | €65.20 71.27 USD |
0
|
€3.58B 3.91B USD | €10.08K 11.02K USD | €51.60 56.41 USD | €52.90 57.83 USD | €3.58B 3.91B USD | 5.75 | €11.32 12.37 USD | ||
| Centessa Pharmaceuticals plc 260.F | €15.00 16.4 USD |
0
|
€3.51B 3.84B USD | €0.00 0 USD | €15.00 16.4 USD | €15.10 16.51 USD | €3.51B 3.84B USD | 0 | -€1.62 -1.7 USD | ||
| Crinetics Pharmaceuticals, Inc. 6Z4.F | €29.80 32.58 USD |
0
|
€3.40B 3.72B USD | €500.00 546.57 USD | €29.80 32.58 USD | €29.80 32.58 USD | €3.40B 3.72B USD | 0 | -€3.89 -4.2 USD | ||
| ACADIA Pharmaceuticals Inc. DR6.F | €19.88 21.73 USD |
0
|
€3.36B 3.68B USD | €140.00 153.04 USD | €19.88 21.73 USD | €19.88 21.73 USD | €3.36B 3.68B USD | 14.94 | €1.33 1.45 USD | ||
| Genscript Biotech Corporation G51.F | €1.46 1.59 USD |
-10.55
|
€3.28B 3.58B USD | €300.00 327.94 USD | €1.46 1.59 USD | €1.46 1.59 USD | €3.28B 3.58B USD | 0 | -€0.03 -0.03 USD | ||
| Camurus AB (publ) 7CA.F | €54.45 59.52 USD |
-1.54
|
€3.26B 3.56B USD | €25.00 27.33 USD | €54.45 59.52 USD | €54.45 59.52 USD | €3.26B 3.56B USD | 45.75 | €1.19 1.3 USD | ||
| BB Biotech AG BBZA.F | €50.30 54.98 USD |
+0.9
|
€3.19B 3.49B USD | €200.00 218.63 USD | €50.00 54.66 USD | €50.30 54.98 USD | €3.19B 3.49B USD | 0 | -€8.60 -9.4 USD | ||
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | €60.10 65.7 USD |
+0.75
|
€3.15B 3.45B USD | €10.00 10.93 USD | €60.10 65.7 USD | €60.10 65.7 USD | €3.15B 3.45B USD | 25.46 | €2.36 2.58 USD | ||
| Ligand Pharmaceuticals Incorporated LGDN.F | €158.00 172.72 USD |
0
|
€3.13B 3.42B USD | €24.00 26.24 USD | €157.00 171.62 USD | €158.00 172.72 USD | €3.13B 3.42B USD | 81.44 | €1.94 2.12 USD | ||
| Ultragenyx Pharmaceutical Inc. UP0.F | €31.20 34.11 USD |
-3.7
|
€3.08B 3.37B USD | €415.00 453.65 USD | €31.20 34.11 USD | €31.20 34.11 USD | €3.08B 3.37B USD | 0 | -€5.13 -5.6 USD | ||
| Telix Pharmaceuticals TLPPF | $9.75 — |
+1.56
|
$3.34B — | $1.00K — | $9.75 — | $9.75 — | $3.34B — | 487.50 | $0.02 — | ||
| Veracyte, Inc. 12V.F | €37.80 41.32 USD |
+0.53
|
€3.01B 3.29B USD | €75.00 81.99 USD | €37.80 41.32 USD | €37.80 41.32 USD | €3.01B 3.29B USD | 114.54 | €0.33 0.36 USD | ||
| Xenon Pharmaceuticals Inc. XP0.F | €38.00 41.54 USD |
-1.04
|
€3.01B 3.29B USD | €81.00 88.54 USD | €38.00 41.54 USD | €38.00 41.54 USD | €3.01B 3.29B USD | 0 | -€3.34 -3.6 USD | ||
| SK bioscience Co.,Ltd. 302440.KS | ₩53,100 40.08 USD |
+0.19
|
₩4T 3.14B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩4T 3.14B USD | 0 | ₩0 0 USD | ||
| BioArctic AB (publ) 0RV2.IL | SEK 320.60 31.29 USD |
+2.36
|
SEK 32.07B 3.13B USD | SEK 1.80K 175.21 USD | SEK 314.80 30.73 USD | SEK 322.40 31.47 USD | SEK 32.07B 3.13B USD | 104.42 | SEK 3.07 0.3 USD | ||
| Ocular Therapeutix, Inc. 0OT.F | €13.42 14.66 USD |
+13.93
|
€2.86B 3.12B USD | €15.00 16.4 USD | €13.42 14.66 USD | €13.66 14.93 USD | €2.86B 3.12B USD | 0 | -€1.23 -1.3 USD | ||
| Viridian Therapeutics, Inc. 1S1.F | €26.98 29.49 USD |
-0.3
|
€2.83B 3.09B USD | €55.00 60.12 USD | €26.98 29.49 USD | €26.98 29.49 USD | €2.83B 3.09B USD | 0 | -€2.60 -2.8 USD | ||
| Mirum Pharmaceuticals, Inc. 08D.F | €55.00 60.12 USD |
-2.65
|
€2.83B 3.09B USD | €10.00 10.93 USD | €55.00 60.12 USD | €56.50 61.76 USD | €2.83B 3.09B USD | 0 | -€0.72 -0.7 USD | ||
| Apellis Pharmaceuticals, Inc. 1JK.F | €21.24 23.21 USD |
+8.47
|
€2.81B 3.07B USD | €20.00 21.86 USD | €19.74 21.58 USD | €21.24 23.21 USD | €2.81B 3.07B USD | 68.50 | €0.31 0.34 USD | ||
| Syngene International Limited SYNGENE.BO | ₹627.15 7.59 USD |
-0.74
|
₹251.94B 3.05B USD | ₹4.80K 58.1 USD | ₹623.75 7.55 USD | ₹634.95 7.68 USD | ₹251.94B 3.05B USD | 53.92 | ₹11.63 0.14 USD | ||
| Liquidia Corporation LT4.MU | €29.76 32.53 USD |
+1.99
|
€2.76B 3.02B USD | €0.00 0 USD | €29.76 32.53 USD | €29.76 32.53 USD | €2.76B 3.02B USD | 0 | -€1.25 -1.3 USD | ||
| Wave Life Sciences Ltd. 1U5.F | €16.50 18.04 USD |
+12.24
|
€2.76B 3.02B USD | €1.43K 1.56K USD | €15.80 17.27 USD | €17.40 19.02 USD | €2.76B 3.02B USD | 0 | -€0.56 -0.6 USD | ||
| IDEAYA Biosciences, Inc. 30J.F | €30.20 33.01 USD |
-1.31
|
€2.70B 2.95B USD | €135.00 147.57 USD | €30.20 33.01 USD | €30.20 33.01 USD | €2.70B 2.95B USD | 0 | -€1.62 -1.7 USD | ||
| Amicus Therapeutics, Inc. AM6.F | €8.40 9.18 USD |
0
|
€2.67B 2.91B USD | €50.00 54.66 USD | €8.40 9.18 USD | €8.40 9.18 USD | €2.67B 2.91B USD | 0 | -€0.03 -0.03 USD | ||
| BioArctic AB (publ) B9A.F | €29.54 32.29 USD |
+5.27
|
€2.62B 2.86B USD | €100.00 109.31 USD | €28.96 31.66 USD | €29.54 32.29 USD | €2.62B 2.86B USD | 28.67 | €1.03 1.13 USD | ||
| IDEAYA Biosciences, Inc. 30J.SG | €29.40 32.14 USD |
-2
|
€2.61B 2.85B USD | €51.00 55.75 USD | €29.40 32.14 USD | €29.40 32.14 USD | €2.61B 2.85B USD | 0 | -€1.62 -1.7 USD | ||
| Denali Therapeutics Inc. 4DN.MU | €17.20 18.8 USD |
-0.06
|
€2.52B 2.76B USD | €0.00 0 USD | €17.20 18.8 USD | €17.20 18.8 USD | €2.52B 2.76B USD | 0 | -€2.51 -2.7 USD | ||
| Liquidia Corporation LT4.SG | €29.76 32.53 USD |
+1.5
|
€2.52B 2.75B USD | €0.00 0 USD | €29.76 32.53 USD | €29.76 32.53 USD | €2.52B 2.75B USD | 0 | -€1.48 -1.6 USD | ||
| Catalyst Pharmaceuticals, Inc. CN2.F | €20.18 22.06 USD |
+1.46
|
€2.48B 2.71B USD | €150.00 163.97 USD | €20.18 22.06 USD | €20.20 22.08 USD | €2.48B 2.71B USD | 13.72 | €1.47 1.61 USD | ||
| Denali Therapeutics Inc. 4DN.F | €16.81 18.38 USD |
-1.32
|
€2.47B 2.69B USD | €133.00 145.39 USD | €16.81 18.38 USD | €16.81 18.38 USD | €2.47B 2.69B USD | 0 | -€2.51 -2.7 USD | ||
| Sarepta Therapeutics, Inc. S1RP34.SA | R$6.01 1.22 USD |
+2.91
|
R$13.20B 2.68B USD | R$10.39K 2.11K USD | R$5.84 1.18 USD | R$6.08 1.23 USD | R$13.20B 2.68B USD | 0 | -R$0.75 -0.1 USD | ||
| Ascentage Pharma Group International 36X.F | €6.45 7.05 USD |
0
|
€2.40B 2.62B USD | €2.05K 2.24K USD | €6.45 7.05 USD | €6.45 7.05 USD | €2.40B 2.62B USD | 0 | -€0.44 -0.4 USD | ||
| Ascletis Pharma ASCLF | $2.24 — |
+86.67
|
$2.34B — | $200.00 — | $2.24 — | $2.24 — | $2.34B — | 0 | -$0.04 — | ||
| Genus GENSF | $35.15 — |
0
|
$2.33B — | $100.00 — | $26.01 — | $26.01 — | $2.33B — | 92.50 | $0.38 — | ||
| Galapagos NV G1LP34.SA | R$8.67 1.76 USD |
+1.52
|
R$11.46B 2.32B USD | R$3.00 0.61 USD | R$8.66 1.76 USD | R$8.67 1.76 USD | R$11.46B 2.32B USD | 0 | -R$2.08 -0.4 USD | ||
| Bavarian Nordic A/S BVNKF | $29.44 — |
+0.62
|
$2.30B — | $200.00 — | $29.26 — | $29.26 — | $2.30B — | 6.15 | $4.78 — | ||
| Bavarian Nordic A/S BVNRY | $9.80 — |
-0.51
|
$2.30B — | $50.00 — | $9.83 — | $9.83 — | $2.30B — | 6.16 | $1.59 — | ||
| Via Transportation, Inc. C0I.F | €24.60 26.89 USD |
-9.56
|
€2.09B 2.28B USD | €113.00 123.52 USD | €24.60 26.89 USD | €26.00 28.42 USD | €2.09B 2.28B USD | 0 | -€1.01 -1.1 USD | ||
| Adaptive Biotechnologies Corporation 1HM.F | €13.05 14.27 USD |
+1.16
|
€2.06B 2.25B USD | €176.00 192.39 USD | €12.66 13.83 USD | €13.09 14.31 USD | €2.06B 2.25B USD | 0 | -€0.45 -0.4 USD | ||
| Mesoblast Limited LWB.F | €1.56 1.71 USD |
+4.7
|
€2.05B 2.24B USD | €1.97K 2.16K USD | €1.56 1.71 USD | €1.57 1.72 USD | €2.05B 2.24B USD | 0 | -€0.09 -0.09 USD | ||
| 89bio ETNB | $14.84 — |
0
|
$2.20B — | $0.00 — | $0.00 — | $0.00 — | $2.20B — | 0 | $0.00 — | ||
| Sarepta Therapeutics, Inc. AB3A.F | €18.54 20.27 USD |
-1.67
|
€2.01B 2.2B USD | €75.00 81.99 USD | €18.54 20.27 USD | €18.54 20.27 USD | €2.01B 2.2B USD | 0 | -€2.43 -2.6 USD | ||
| Adaptive Biotechnologies Corporation 1HM.MU | €12.91 14.11 USD |
0
|
€2.01B 2.2B USD | €0.00 0 USD | €12.91 14.11 USD | €12.91 14.11 USD | €2.01B 2.2B USD | 0 | -€0.45 -0.4 USD | ||
| Bavarian Nordic A/S BV3.F | €25.17 27.51 USD |
+0.28
|
€2.00B 2.19B USD | €100.00 109.31 USD | €25.17 27.51 USD | €25.17 27.51 USD | €2.00B 2.19B USD | 6.12 | €4.11 4.49 USD | ||
| BAVARIAN NORDIC N BV3.DE | €25.33 27.69 USD |
-0.55
|
€1.98B 2.17B USD | €40.00 43.73 USD | €25.33 27.69 USD | €25.57 27.95 USD | €1.98B 2.17B USD | 6.16 | €4.11 4.49 USD | ||
| Genus plc GBE.F | €29.60 32.36 USD |
-2.63
|
€1.97B 2.15B USD | €3.00 3.28 USD | €29.60 32.36 USD | €29.60 32.36 USD | €1.97B 2.15B USD | 89.69 | €0.33 0.36 USD | ||
| Galapagos GLPGF | $31.29 — |
0
|
$2.06B — | $190.00 — | $26.20 — | $26.20 — | $2.06B — | 0 | -$7.85 — | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||